FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 3000536 · Received March 12, 2013

Report

Report Number
2134265-2013-01401
Event Type
Injury
Date Received
March 12, 2013
Date of Event
January 10, 2013
Report Date
February 12, 2013
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4)

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

IT WAS FURTHER REPORTED THAT IN (B)(6) 2013 THE SUBJECT UNDERWENT LEFT HEART CATHETERIZATION AND CORONARY ARTERY BYPASS PROCEDURE. CATHETERIZATION REVEALED LEFT VENTRICULAR EJECTION FRACTION OF 40%, MILD AORTIC STENOSIS, AND GRADE-I TRIVIAL AORTIC REGURGITATION. NO FURTHER INTERVENTION WAS PERFORMED.

Description of Event or Problem · 1

(B)(4) TRIAL. IT WAS REPORTED THAT FOLLOWING A PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, THE PATIENT EXPERIENCED CHEST PAIN. THE TARGET LESION WAS LOCATED IN THE MID RIGHT CORONARY ARTERY (RCA). THE 3.0X12MM TAXUS LIBERTE STENT WAS SUCCESSFULLY IMPLANTED. ADDITIONAL PTCA TREATED A LESION IN THE OBTUSE MARGINAL ARTERY. POST PROCEDURE RESIDUAL STENOSIS WAS 0% WITH TIMI II FLOW. PATIENT WAS DISCHARGED ON CLOPIDOGREL. IN (B)(6) 2013, 787 POST INDEX PROCEDURE THE PATIENT EXPERIENCED CHEST PAIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
102791 TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE UNK433

Patients

Seq Age Sex Outcome Treatment
1 65 YR Other